数据资源简介:挪威药物利用和药物流行病学数据库

Q3 Medicine Norsk Epidemiologi Pub Date : 2021-08-16 DOI:10.5324/nje.v29i1-2.4040
H. Sommerschild, C. Berg, C. Jonasson, Kari Jansdotter Husabø, M. N. Sharikabad
{"title":"数据资源简介:挪威药物利用和药物流行病学数据库","authors":"H. Sommerschild, C. Berg, C. Jonasson, Kari Jansdotter Husabø, M. N. Sharikabad","doi":"10.5324/nje.v29i1-2.4040","DOIUrl":null,"url":null,"abstract":"In this article we aim to give researchers and other users of drug utilization data a current overview of the twonationwide Norwegian drug databases located at the Norwegian Institute of Public Health (NIPH), withreference to some historical background. The first database, “The Norwegian Drug Wholesales Statistics”,dating back to 1974, provides total sale figures of all medicines on the market. The second database, “TheNorwegian Prescription Database” (NorPD), dates back to 2004 and covers prescription drugs dispensed bypharmacies. This database will be modernized during 2021 and renamed (“The Norwegian Prescribed DrugRegistry”, name not finally decided), and all historical data will be migrated to the modernized registry. In thefuture, the most valuable add-on to the modernized prescription database will be individual level data fromin-patients in hospitals and health care institutions, and the possibility to obtain aggregated data from eachinstitution. Together, the two nationwide databases will continue to be the cornerstones of drug utilization data in Norway and should be used more extensively to improve health to the best for individuals and society. Development in national e-health programs will play a key role in providing easier and less time-consuming access to data and improve conditions for linkage of drug data to other health registries in the near future.","PeriodicalId":35548,"journal":{"name":"Norsk Epidemiologi","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Data resource profile: Norwegian Databases for Drug Utilization and Pharmacoepidemiology\",\"authors\":\"H. Sommerschild, C. Berg, C. Jonasson, Kari Jansdotter Husabø, M. N. Sharikabad\",\"doi\":\"10.5324/nje.v29i1-2.4040\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this article we aim to give researchers and other users of drug utilization data a current overview of the twonationwide Norwegian drug databases located at the Norwegian Institute of Public Health (NIPH), withreference to some historical background. The first database, “The Norwegian Drug Wholesales Statistics”,dating back to 1974, provides total sale figures of all medicines on the market. The second database, “TheNorwegian Prescription Database” (NorPD), dates back to 2004 and covers prescription drugs dispensed bypharmacies. This database will be modernized during 2021 and renamed (“The Norwegian Prescribed DrugRegistry”, name not finally decided), and all historical data will be migrated to the modernized registry. In thefuture, the most valuable add-on to the modernized prescription database will be individual level data fromin-patients in hospitals and health care institutions, and the possibility to obtain aggregated data from eachinstitution. Together, the two nationwide databases will continue to be the cornerstones of drug utilization data in Norway and should be used more extensively to improve health to the best for individuals and society. Development in national e-health programs will play a key role in providing easier and less time-consuming access to data and improve conditions for linkage of drug data to other health registries in the near future.\",\"PeriodicalId\":35548,\"journal\":{\"name\":\"Norsk Epidemiologi\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Norsk Epidemiologi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5324/nje.v29i1-2.4040\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Norsk Epidemiologi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5324/nje.v29i1-2.4040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 6

摘要

在本文中,我们旨在参考一些历史背景,向研究人员和其他药物使用数据使用者介绍位于挪威公共卫生研究所(NIPH)的两个全国性挪威药物数据库的最新概况。第一个数据库“挪威药品批发统计”可追溯到1974年,提供了市场上所有药品的总销售数字。第二个数据库,“挪威处方数据库”(NorPD),可追溯到2004年,涵盖制药公司配制的处方药。该数据库将在2021年进行现代化改造并更名(“挪威处方药注册中心”,名称尚未最终确定),所有历史数据将迁移到现代化的注册中心。未来,现代化处方数据库中最有价值的附加内容将是来自医院和医疗保健机构内部患者的个人层面数据,以及从每个机构获得汇总数据的可能性。这两个全国性数据库将继续成为挪威药物使用数据的基石,应更广泛地用于改善个人和社会的健康状况。在不久的将来,国家电子健康计划的发展将在提供更容易、更耗时的数据访问方面发挥关键作用,并改善将药物数据与其他健康登记处联系起来的条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Data resource profile: Norwegian Databases for Drug Utilization and Pharmacoepidemiology
In this article we aim to give researchers and other users of drug utilization data a current overview of the twonationwide Norwegian drug databases located at the Norwegian Institute of Public Health (NIPH), withreference to some historical background. The first database, “The Norwegian Drug Wholesales Statistics”,dating back to 1974, provides total sale figures of all medicines on the market. The second database, “TheNorwegian Prescription Database” (NorPD), dates back to 2004 and covers prescription drugs dispensed bypharmacies. This database will be modernized during 2021 and renamed (“The Norwegian Prescribed DrugRegistry”, name not finally decided), and all historical data will be migrated to the modernized registry. In thefuture, the most valuable add-on to the modernized prescription database will be individual level data fromin-patients in hospitals and health care institutions, and the possibility to obtain aggregated data from eachinstitution. Together, the two nationwide databases will continue to be the cornerstones of drug utilization data in Norway and should be used more extensively to improve health to the best for individuals and society. Development in national e-health programs will play a key role in providing easier and less time-consuming access to data and improve conditions for linkage of drug data to other health registries in the near future.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Norsk Epidemiologi
Norsk Epidemiologi Medicine-Epidemiology
CiteScore
1.10
自引率
0.00%
发文量
25
审稿时长
12 weeks
期刊最新文献
The impact of longitudinal surveillance of individuals with CP in Norway; a 20-year quality registry and follow-up program perspective Nasjonalt register for gastrokirurgi (NORGAST): noen tanker etter ti år External validation of SAPS II score reported to the Norwegian Intensive Care and Pandemic Registry (NIPaR) MS-registeret: meget viktig for MS-pasientene og enda viktigere fremover Et lederperspektiv – nytten av medisinske kvalitetsregistre og hvordan vi bruker disse i forbedringsarbeid og praksisendring
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1